TY - JOUR
T1 - Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung
AU - Miki, Makoto
AU - Ball, Douglas W.
AU - Linnoila, R. Ilona
N1 - Funding Information:
We thank Drs. Michael Birrer and Eva Szabo for stimulating and critical discussions of this work, and Sandy Jensen and Dr. Mae Jean Miller for technical assistance. This work was funded by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research .
PY - 2012/1
Y1 - 2012/1
N2 - Achaete-scute homolog-1 (ASH1) is pivotal for the development of pulmonary neuroendocrine (NE) cells. We examined human ASH1 (hASH1) expression across a comprehensive panel of human lung cancer cell lines, primary human lung tumors and normal fetal and post-natal lungs. While hASH1 was a cardinal feature of NE carcinomas, a subgroup of non-NE lung cancers also exhibited expression of this factor. Twenty lung cancer cell lines out of 33 were positive for hASH1 mRNA by reverse transcription PCR, including 6/6 small cell carcinomas (SCLC), 5/5 carcinoids, 6/7 non-SCLC with NE features, and 3/14 other non-SCLC. Among human primary tumors, 2/2 SCLC, 5/5 pulmonary carcinoids, and 10/41 non-SCLC (only 4 of which had NE features) were positive for hASH1 by immunohistochemistry and RNA-RNA in situ hybridization. In normal human fetal lung, the expression of hASH1 and the neural marker synaptophysin was highly concordant in neuroepithelial bodies and solitary NE cells, while the rest of the epithelium was negative. In childhood and adulthood, the markers became progressively discordant, with a majority of hASH1-immunoreactive foci (69%) being negative for synaptophysin in adults, potentially representing dormant NE cell progenitors. We conclude that hASH1 provides an early indication of NE program in human lung.
AB - Achaete-scute homolog-1 (ASH1) is pivotal for the development of pulmonary neuroendocrine (NE) cells. We examined human ASH1 (hASH1) expression across a comprehensive panel of human lung cancer cell lines, primary human lung tumors and normal fetal and post-natal lungs. While hASH1 was a cardinal feature of NE carcinomas, a subgroup of non-NE lung cancers also exhibited expression of this factor. Twenty lung cancer cell lines out of 33 were positive for hASH1 mRNA by reverse transcription PCR, including 6/6 small cell carcinomas (SCLC), 5/5 carcinoids, 6/7 non-SCLC with NE features, and 3/14 other non-SCLC. Among human primary tumors, 2/2 SCLC, 5/5 pulmonary carcinoids, and 10/41 non-SCLC (only 4 of which had NE features) were positive for hASH1 by immunohistochemistry and RNA-RNA in situ hybridization. In normal human fetal lung, the expression of hASH1 and the neural marker synaptophysin was highly concordant in neuroepithelial bodies and solitary NE cells, while the rest of the epithelium was negative. In childhood and adulthood, the markers became progressively discordant, with a majority of hASH1-immunoreactive foci (69%) being negative for synaptophysin in adults, potentially representing dormant NE cell progenitors. We conclude that hASH1 provides an early indication of NE program in human lung.
KW - Achaete-scute homolog-1
KW - Human
KW - Lung carcinogenesis
KW - Lung development
KW - Neuroendocrine
KW - Non-small cell lung cancer
KW - Small cell lung cancer
KW - Synaptophysin
UR - http://www.scopus.com/inward/record.url?scp=83555165213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83555165213&partnerID=8YFLogxK
U2 - 10.1016/j.lungcan.2011.05.019
DO - 10.1016/j.lungcan.2011.05.019
M3 - Article
C2 - 21684625
AN - SCOPUS:83555165213
SN - 0169-5002
VL - 75
SP - 58
EP - 65
JO - Lung Cancer
JF - Lung Cancer
IS - 1
ER -